228 related articles for article (PubMed ID: 34889405)
1. Impaired myelopoiesis in congenital neutropenia: insights into clonal and malignant hematopoiesis.
Warren JT; Link DC
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):514-520. PubMed ID: 34889405
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of leukemic transformation in congenital neutropenia.
Link DC
Curr Opin Hematol; 2019 Jan; 26(1):34-40. PubMed ID: 30431463
[TBL] [Abstract][Full Text] [Related]
3. Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformation.
Choi SW; Boxer LA; Pulsipher MA; Roulston D; Hutchinson RJ; Yanik GA; Cooke KR; Ferrara JL; Levine JE
Bone Marrow Transplant; 2005 Mar; 35(5):473-7. PubMed ID: 15640815
[TBL] [Abstract][Full Text] [Related]
4. Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias.
Freedman MH; Alter BP
Semin Hematol; 2002 Apr; 39(2):128-33. PubMed ID: 11957196
[TBL] [Abstract][Full Text] [Related]
5. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy.
Freedman MH; Bonilla MA; Fier C; Bolyard AA; Scarlata D; Boxer LA; Brown S; Cham B; Kannourakis G; Kinsey SE; Mori PG; Cottle T; Welte K; Dale DC
Blood; 2000 Jul; 96(2):429-36. PubMed ID: 10887102
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study.
Myers KC; Furutani E; Weller E; Siegele B; Galvin A; Arsenault V; Alter BP; Boulad F; Bueso-Ramos C; Burroughs L; Castillo P; Connelly J; Davies SM; DiNardo CD; Hanif I; Ho RH; Karras N; Manalang M; McReynolds LJ; Nakano TA; Nalepa G; Norkin M; Oberley MJ; Orgel E; Pastore YD; Rosenthal J; Walkovich K; Larson J; Malsch M; Elghetany MT; Fleming MD; Shimamura A
Lancet Haematol; 2020 Mar; 7(3):e238-e246. PubMed ID: 31879230
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel
Connelly JA; Mody RJ; Wu YM; Robinson DR; Lonigro RJ; Vats P; Rabban E; Anderson B; Walkovich K
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29572239
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations and clonal hematopoiesis in congenital neutropenia.
Xia J; Miller CA; Baty J; Ramesh A; Jotte MRM; Fulton RS; Vogel TP; Cooper MA; Walkovich KJ; Makaryan V; Bolyard AA; Dinauer MC; Wilson DB; Vlachos A; Myers KC; Rothbaum RJ; Bertuch AA; Dale DC; Shimamura A; Boxer LA; Link DC
Blood; 2018 Jan; 131(4):408-416. PubMed ID: 29092827
[TBL] [Abstract][Full Text] [Related]
9. Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia.
Savage SA; Dufour C
Semin Hematol; 2017 Apr; 54(2):105-114. PubMed ID: 28637614
[TBL] [Abstract][Full Text] [Related]
10. Malignant myeloid transformation in congenital forms of neutropenia.
Freedman MH; Alter BP
Isr Med Assoc J; 2002 Nov; 4(11):1011-4. PubMed ID: 12489493
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell transplantation in severe congenital neutropenia.
Carlsson G; Winiarski J; Ljungman P; Ringdén O; Mattsson J; Nordenskjöld M; Touw I; Henter JI; Palmblad J; Fadeel B; Hägglund H
Pediatr Blood Cancer; 2011 Mar; 56(3):444-51. PubMed ID: 21072829
[TBL] [Abstract][Full Text] [Related]
12. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.
Rosenberg PS; Alter BP; Bolyard AA; Bonilla MA; Boxer LA; Cham B; Fier C; Freedman M; Kannourakis G; Kinsey S; Schwinzer B; Zeidler C; Welte K; Dale DC;
Blood; 2006 Jun; 107(12):4628-35. PubMed ID: 16497969
[TBL] [Abstract][Full Text] [Related]
13. Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia.
Kalra R; Dale D; Freedman M; Bonilla MA; Weinblatt M; Ganser A; Bowman P; Abish S; Priest J; Oseas RS; Olson K; Paderanga D; Shannon K
Blood; 1995 Dec; 86(12):4579-86. PubMed ID: 8541548
[TBL] [Abstract][Full Text] [Related]
14. Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy.
Rosenberg PS; Zeidler C; Bolyard AA; Alter BP; Bonilla MA; Boxer LA; Dror Y; Kinsey S; Link DC; Newburger PE; Shimamura A; Welte K; Dale DC
Br J Haematol; 2010 Jul; 150(2):196-9. PubMed ID: 20456363
[TBL] [Abstract][Full Text] [Related]
15.
Olofsen PA; Touw IP
Mol Cells; 2020 Feb; 43(2):139-144. PubMed ID: 32041395
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal aberrations in congenital bone marrow failure disorders--an early indicator for leukemogenesis?
Göhring G; Karow A; Steinemann D; Wilkens L; Lichter P; Zeidler C; Niemeyer C; Welte K; Schlegelberger B
Ann Hematol; 2007 Oct; 86(10):733-9. PubMed ID: 17653548
[TBL] [Abstract][Full Text] [Related]
17. Congenital neutropenia: disease models guiding new treatment strategies.
Touw IP
Curr Opin Hematol; 2022 Jan; 29(1):27-33. PubMed ID: 34854832
[TBL] [Abstract][Full Text] [Related]
18. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
Babushok DV; Bessler M
Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
[TBL] [Abstract][Full Text] [Related]
19. Ultra-Sensitive
Klimiankou M; Uenalan M; Kandabarau S; Nustede R; Steiert I; Mellor-Heineke S; Zeidler C; Skokowa J; Welte K
Front Immunol; 2019; 10():116. PubMed ID: 30891028
[TBL] [Abstract][Full Text] [Related]
20. Lethal sepsis and malignant transformation in severe congenital neutropenia: report from the Italian Neutropenia Registry.
Fioredda F; Calvillo M; Lanciotti M; Cefalo MG; Tucci F; Farruggia P; Casazza G; Martire B; Bonanomi S; Notarangelo L; Barone A; Palazzi G; Davitto M; Barella S; Cardinale F; Mastrodicasa E; Cugno C; Russo G; Caviglia I; Caruso S; Castagnola E; Dufour C
Pediatr Blood Cancer; 2015 Jun; 62(6):1110-2. PubMed ID: 25619745
[No Abstract] [Full Text] [Related]
[Next] [New Search]
